A series of 6,8-diiodocoumarin-3-N-carboxamides (4-11) were prepared. Treatment of ethyl 6,8-diiodocoumarin-3-carboxylate (1) with ethyl cyanoacetate/NH 4 OAc gave ethyl 2-(3-carbamoyl-6,8-diiodocoumarin-4-yl)-2-cyanoacetate (12) and 2-amino-4-hydroxy-7,9-diiodocoumarino[3,4-c]pyridine-1-carbonitrile (13), and treatment with acetone in the presence of NH 4 OAc or methylamine gave the ethyl 4-oxo-2,6-methano-2-methyl-3,4,5,6-tetrahydro-8,10-diiodobenzo[2,1-g]-2H-1,3-oxazocine-5-carboxylate derivatives 14a,b. All compounds were evaluated for their antimicrobial activity and the compounds 12-14a,b exhibited a pronounced effect on all tested microorganisms.
Introduction
Coumarins and their derivatives are biologically and pharmaceutically interesting compounds known for their use as additives in food, perfumes, cosmetics, pharmaceuticals, platelet aggregation and agrochemicals [1, 2] . Coumarins have also been reported to exhibit several biological activities, such as antimicrobial, anticancer, antifungal, anti-HIV and antioxidant properties [3] [4] [5] [6] , and they also served as versatile precursors for many organic transformations in the synthesis of a number of drug-like molecules [7, 8] . Moreover, coumarin-based dyes and pigments are organic fluorescent materials exhibiting unique photochemical and photophysical properties, which render them useful in a variety of applications such as dye lasers, anion sensors, organic light-emitting diodes and solar cells [9, 10] .
Iodo-organic derivatives have been widely used as diagnosticimaging drugs (such as diatrizoate meglumine, diatrizoic acid, iodipamide, iodixanol, iohexol, iomeprol and iopamidol) and as amebicides [11, 12] . The benzoxazocine derivatives have received considerable attention due to their pharmacological properties, such as their antidepressant, antithrombotic, antipsychotic (for the central nervous system, CNS) and anti-breastcancer activities [13] .
In view of the important biological properties of the diiodocoumarin derivatives and iodo-organic compounds as medical agents, we planned to synthesize some new diiodocoumarin derivatives bearing side chains with different structures, as such derivatives could possess interesting and useful biological properties.
Results and Discussion
Interaction of 3,5-diiodosalicylaldehyde with diethyl malonate according to the literature procedure [14, 15] afforded ethyl 6,8-diiodocoumarin-3-carboxylate (1) . Treatment of 1 with hot ethanolic KOH (10%) followed by acidification with HCl gave the corresponding 6,8-diiodocoumarin-3-carboxylic acid (2) , which on treatment with SOCl 2 gave the 6,8-diiodocoumarin-3-carbonyl chloride (3) . Treatment of 1 with piperidine in boiling ethanol or with p-phenylenediamine in boiling AcOH afforded the 6,8-diiodocoumarin-3-carboxamide derivatives 4 and 5, respectively. Interaction of 3 with glycine in dry benzene under reflux gave the new 6,8-diiodocoumarin-3-N,N-dimethylcarboxamide (7) instead of 6,8-diiodocoumarin-3-ylcarbonylglycine (6) . The formation of compound 7 suggests that two glycine molecules react with 1 followed by the loss of ammonia and decarboxylation, furnishing the observed product (Scheme 1).
The structures of compounds 3-5 and 7 were confirmed by IR, 1 H NMR, 13 C NMR and MS. The IR spectra for compound 3 showed 1774, 1718 cm −1 (2 CO); for compound 4 1713, 1631 cm −1 (2 CO); for compound 5 1718 cm −1 (CO); and for compound 7 1722, 1635 cm −1 (2 CO). 1 H NMR for compounds 3-5 and 7 showed δ at 7.64-8.70 ppm (s, 1H, H-4), and 13 C NMR for compounds 3 and 5 showed δ at 143.2 and 147.2 ppm (C-4), respectively. The mass spectra of compounds 3 and 7 showed the corresponding molecular ion peaks at m/z 460 (M + , 2.6%) and m/z 469 (M + , 18.5%). The fragmentation pattern of compounds 3 and 7 are illustrated in Scheme 2. Reactions of 3 with 4-aminophenylethanol or p-aminophenol, or with potentially bifunctional amino acids (anthranilic acid and p-aminophenylacetic acid), was successful, and the corresponding 6,8-diiodocoumarin-3-carboxamide derivatives 8-11 were obtained (Scheme 3).
The structures of compounds 8-11 were established by IR, 1 H NMR, 13 C NMR and MS. The IR spectra of compound 8 showed 3287 cm -1 (OH, NH) and 1719 cm -1 (CO) and for compound 9 3217 cm -1 (NH, OH) and 1720 cm -1 (CO). 1 13 C NMR for 11 showed δ at 160 (CO δ lactone), 163.4 (CONH), and 176.5 ppm (COOH). The mass spectra of compounds 8-11 provided additional evidence for the proposed structures.
As the C3-C4 olefinic bond in ethyl 6,8-diiodocoumarin-3-carboxylate (1) is activated by conjugation with electron-withdrawing carbonyl groups, the behavior of 1 towards activated methylene compounds under Michael reaction conditions was investigated. Thus, treatment of 1 with ethyl cyanoacetate/ NH 4 OAc in boiling ethanol afforded two reaction products. The insoluble reaction product was identified as ethyl 2-(3-carbamoyl-6,8-diiodocoumarin-4-yl)-2-cyanoacetate (12) and the soluble reaction product was identified as 2-amino-4-hydroxy-7,9-diiodocoumarino[3,4-c]pyridine-1-carbonitrile (13) , which probably formed as a result of amide formation, dehydration and intramolecular cyclization (Scheme 4).
The structures of compounds 12 and 13 were established by IR, 1 H NMR, 13 C NMR and MS. The IR spectra of compound 12 showed 3309, 3277 cm -1 (NH 2 ), 2206 cm -1 (CN), and 1643 cm -1 (CO), while the 1 H NMR for compound 13 showed δ at 7.89 (brs, 2H, NH 2 ), and 9.06 (brs, 1H, OH). The spectral data of compound 13 confirmed its enol structure.
Reaction of 1 with acetone in the presence of NH 4 OAc or methylamine at room temperature for 7 days gave 1,3-oxazocine-5-carboxylate derivatives (14a,b) [16-18] (Scheme 5). The formation of 14 indicates that the activated methylene compounds attack at the C3-C4 olefinic bond in 1 under Michael reaction conditions to yield a cyclic Michael adduct, which underwent hydrolysis by NH 3 or MeNH 2 and cyclization through the elimination of H 2 O (Scheme 5).
The structure of compound 14a was established by 13 C NMR, which showed δ at 42.5 (CH 2 (c)), 168.4 cm -1 (CONH), and 170 cm -1 (CO). The structures of all newly synthesized compounds were confirmed by IR, 1 H NMR, 13 C NMR and mass spectrometry.
The inhibitory effects of the synthetic compounds against these organisms are given in Table 1 , Figure 1 (NCTC-7447), Bacillus cereus (ATCC-14579) and two Gramnegative bacteria, Escherichia coli (NCTC-10410) and Serratia marcescens (IMRU-70), while the same compounds showed moderate antifungal activity against the tested organisms. Compounds 9-11 exhibited comparable activity to ampicillin against the tested bacteria and moderate to weak antifungal activity against the tested organisms. Furthermore, compounds 1-8 showed moderate to weak activities against all the tested bacteria and fungi, compared with the standards ampicillin and calforan. In addition, compounds 2 and 5 in the series were found to be inactive against Escherichia coli (NCTC-10410), while compound 11 was inactive against Serratia marcescens (IMRU-70). An investigation of the structure-activity relationship (SAR) revealed that the activity is considerably affected by the presence of the diiodocoumarino [3,4- 
oxazocine, and slightly decreases with the presence of different amide groups at position C-3 of the diiodocoumarin moiety or with the presence of ester, acid or acid chloride at position C-3 of the diiodocoumarin moiety.
Experimental General methods
Melting points were determined on a Stuart melting point apparatus and are uncorrected; IR spectra were recorded in KBr on a FT-IR 5300 spectrometer and Perkin Elmer spectrum RXIFT-IR system (ν, cm −1 
6,8-Diiodo-3-(piperidine-1-carbonyl)coumarin (4).
A solution of compound 1 (0.47 g, 10 mmol) in absolute ethanol (30 mL) was refluxed with piperidine (0.9 g, 10 mmol) for 1 h. After cooling, the solid formed was filtered off, washed with ethanol and dried under vacuum. 
N-(4-Acetamidophenyl)-6,8-diiodocoumarin-3-carboxamide (5).

6,8-Diiodocoumarin-3-N,N-dimethylcarboxamide (7).
A solution of compound 3 (0.46 g, 1 mmol) in dry benzene (50 mL) was refluxed with glycine (0.75 g, 10 mmol) for 2 h. After cooling, the solid formed was filtered off, washed with ethanol, dried under vacuum, and recrystallized from dioxane. General procedure for the synthesis of 6,8-diiodocoumarin-3-carboxamide derivatives
8-11
To a well-stirred solution of 3 (0.46 g, 1 mmol) in dry dichloromethane (DCM) containing a few drops of triethylamine (TEA) an equivalent amount of an ambient nucleophile [4-aminophenylethanol, p-aminophenol, anthranilic acid and p-aminophenylacetic acid (1.2 mmol)] was added. The reaction mixture was stirred at room temperature under dry conditions for 3 h. DCM was removed under reduced pressure until dryness, the obtained solid was then washed with 10% HCl and the remaining solid recrystallized from dioxane. General procedure for the synthesis of 1,3-oxazocine-5-carboxylate derivatives 14a,b
N-(4-(2-Hydroxyethyl)phenyl)-6,8-diiodocoumarin-3-carboxamide (8).
A mixture of compound 1 (2.35 g, 5 mmol), acetone (30 mL) and (a) ammonium acetate (0.4 g, 5 mmol) or (b) methylamine (0.16 g, 5 mmol) was stirred at room temperature for 7 days. In both cases a colorless solid formed after the solvent had evaporated under reduced pressure, and the products were identified as compounds 14a and 14b. The crude products were crystallized from benzene.
tested compounds were dissolved in N,N-dimethylformamide (DMF) to give a solution of 1 mg mL −1 . The inhibition zones (diameter of the hole) were measured in millimeters (6 mm) at the end of an incubation period of 48 h at 28 °C; N,N-dimethylformamide showed no inhibition zone.
Conclusion
It was interesting to note that four of the new compounds (12, 13 and 14a,b) were found to have an antimicrobial activity greater than that of the standard antibiotic ampicillin or the standard antifungal claforan, while compounds 1-11 were either inactive or only weakly active against the tested microorganisms. The presence of fused diiodocoumarino [3,4-c] pyridine and diiodobenzo[2,1-g]-2H-1,3-oxazocine nucleus increased the antimicrobial activity, whereas the presence of diiodocoumarin-3-carboxamides decreased the antimicrobial activity.
